Monday, November 20, 2006

pulmonary arterial hypertension (PAH) Swiss Co. buys out smaller pharma for a mere inhalable version... ha!

ENCY Jan and April Calls, shoot up 25%, ENCY closes well above $6.00. For a simple Volatility premium going into Dec(FDA panel review on Thelin), and further sympathy buyouts in the sector, ENCY April Call, bids at .90 would be key, but if you missed the .90 prints the past few days, it might be too late. As for January, the corresponding edge is .55, but now it's .55-.85, really wide, so if you get a fill in the .60-.65 range, you might very well be solidly poised before expiration in 2007, and a 21 GUN SALUTE to the follied person who sold you those calls.

We're just a battery for hire with the guitar fire...Ready and aimed at you...Pick up your balls and load up your cannon... For a twenty-one gun salute....


Post a Comment

Links to this post:

Create a Link

<< Home